Literature DB >> 28378503

IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration.

M W Johansson1, M Khanna1, V Bortnov1, D S Annis1, C L Nguyen1, D F Mosher1,2.   

Abstract

BACKGROUND: IL-5 causes suspended eosinophils to polarize with filamentous (F)-actin and granules at one pole and the nucleus in a specialized uropod, the "nucleopod," which is capped with P-selectin glycoprotein ligand-1 (PSGL-1). IL-5 enhances eosinophil adhesion and migration on periostin, an extracellular matrix protein upregulated in asthma by type 2 immunity mediators.
OBJECTIVE: Determine how the polarized morphology evolves to foster migration of IL-5-stimulated eosinophils on a surface coated with periostin.
METHODS: Blood eosinophils adhering to adsorbed periostin were imaged at different time points by fluorescent microscopy, and migration of eosinophils on periostin was assayed.
RESULTS: After 10 minutes in the presence of IL-5, adherent eosinophils were polarized with PSGL-1 at the nucleopod tip and F-actin distributed diffusely at the opposite end. After 30-60 minutes, the nucleopod had dissipated such that PSGL-1 was localized in a crescent or ring away from the cell periphery, and F-actin was found in podosome-like structures. The periostin layer, detected with monoclonal antibody Stiny-1, shown here to recognize the FAS1 4 module, was cleared in wide areas around adherent eosinophils. Clearance was attenuated by metalloproteinase inhibitors or antibodies to disintegrin metalloproteinase 8 (ADAM8), a major eosinophil metalloproteinase previously implicated in asthma pathogenesis. ADAM8 was not found in podosome-like structures, which are associated with proteolytic activity in other cell types. Instead, immunoblotting demonstrated proteoforms of ADAM8 that lack the cytoplasmic tail in the supernatant. Anti-ADAM8 inhibited migration of IL-5-stimulated eosinophils on periostin. CONCLUSIONS AND CLINICAL RELEVANCE: Migrating IL-5-activated eosinophils on periostin exhibit loss of nucleopodal features and appearance of prominent podosomes along with clearance of the Stiny-1 periostin epitope. Migration and epitope clearance are both attenuated by inhibitors of ADAM8. We propose, therefore, that eosinophils remodel and migrate on periostin-rich extracellular matrix in the asthmatic airway in an ADAM8-dependent manner, making ADAM8 a possible therapeutic target.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  ADAM8; FAS1 modules; IL-5; Stiny-1; eosinophils; migration; periostin; podosomes

Mesh:

Substances:

Year:  2017        PMID: 28378503      PMCID: PMC5623171          DOI: 10.1111/cea.12934

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  53 in total

1.  The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.

Authors:  Uwe Schlomann; Dirk Wildeboer; Ailsa Webster; Olga Antropova; Dagmar Zeuschner; C Graham Knight; Andrew J P Docherty; Marc Lambert; Lisa Skelton; Harald Jockusch; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

2.  Expression of ADAMs and their inhibitors in sputum from patients with asthma.

Authors:  Geneviève Paulissen; Natacha Rocks; Florence Quesada-Calvo; Philippe Gosset; Jean-Michel Foidart; Agnès Noel; Renaud Louis; Didier D Cataldo
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

Review 3.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

4.  Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.

Authors:  Sally Wenzel; Mario Castro; Jonathan Corren; Jorge Maspero; Lin Wang; Bingzhi Zhang; Gianluca Pirozzi; E Rand Sutherland; Robert R Evans; Vijay N Joish; Laurent Eckert; Neil M H Graham; Neil Stahl; George D Yancopoulos; Mariana Louis-Tisserand; Ariel Teper
Journal:  Lancet       Date:  2016-04-27       Impact factor: 79.321

Review 5.  Eosinophil trafficking in allergy and asthma.

Authors:  Helene F Rosenberg; Simon Phipps; Paul S Foster
Journal:  J Allergy Clin Immunol       Date:  2007-05-03       Impact factor: 10.793

6.  Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma.

Authors:  Yoshihiko Chiba; Satoshi Onoda; Yoshiyuki Hattori; Yoshie Maitani; Hiroyasu Sakai; Miwa Misawa
Journal:  Lung       Date:  2009-04-17       Impact factor: 2.584

7.  Sputum ADAM8 expression is increased in severe asthma and COPD.

Authors:  K M Oreo; P G Gibson; J L Simpson; L G Wood; V M McDonald; K J Baines
Journal:  Clin Exp Allergy       Date:  2014-03       Impact factor: 5.018

8.  ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.

Authors:  Christian Herzog; Randy S Haun; Andreas Ludwig; Sudhir V Shah; Gur P Kaushal
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

9.  Roles of periostin in symptom manifestation and airway remodeling in a murine model of allergic rhinitis.

Authors:  Dong Gu Hur; Roza Khalmuratova; Seong-Ki Ahn; Young-Sool Ha; Yang-Gi Min
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-08       Impact factor: 5.764

10.  Integrin activation States and eosinophil recruitment in asthma.

Authors:  Mats W Johansson; Deane F Mosher
Journal:  Front Pharmacol       Date:  2013-04-01       Impact factor: 5.810

View more
  11 in total

1.  Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge.

Authors:  Mats W Johansson; Elizabeth A Kelly; Christopher L Nguyen; Nizar N Jarjour; Bruce S Bochner
Journal:  Int Arch Allergy Immunol       Date:  2018-06-07       Impact factor: 2.749

2.  Eosinophil cytolysis on Immunoglobulin G is associated with microtubule formation and suppression of rho-associated protein kinase signalling.

Authors:  Stephane Esnault; Jonathan P Leet; Mats W Johansson; Karina T Barretto; Paul S Fichtinger; Frances J Fogerty; Ksenija Bernau; Sameer K Mathur; Deane F Mosher; Nathan Sandbo; Nizar N Jarjour
Journal:  Clin Exp Allergy       Date:  2019-12-09       Impact factor: 5.018

Review 3.  Eosinophil Activation Status in Separate Compartments and Association with Asthma.

Authors:  Mats W Johansson
Journal:  Front Med (Lausanne)       Date:  2017-06-12

Review 4.  Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia.

Authors:  Kazuyuki Nakagome; Makoto Nagata
Journal:  Biomolecules       Date:  2020-04-21

5.  Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.

Authors:  Sarah B Gitto; Jordan M Beardsley; Sai Preethi Nakkina; Jeremiah L Oyer; Kathryn A Cline; Sally A Litherland; Alicja J Copik; Amr S Khaled; Na'im Fanaian; J Pablo Arnoletti; Deborah A Altomare
Journal:  Cell Commun Signal       Date:  2020-06-17       Impact factor: 5.712

Review 6.  The Airway Epithelium-A Central Player in Asthma Pathogenesis.

Authors:  Jenny Calvén; Elisabeth Ax; Madeleine Rådinger
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

Review 7.  Role of periostin in ECRS.

Authors:  Lei Yu; Jisheng Wang; Kai Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-21       Impact factor: 2.503

8.  Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin.

Authors:  Karina T Barretto; Calvin M Swanson; Christopher L Nguyen; Douglas S Annis; Stephane J Esnault; Deane F Mosher; Mats W Johansson
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

Review 9.  Comorbidity of Neurally Mediated Syncope and Allergic Disease in Children.

Authors:  Yaru Wang; Junbao Du; Hongfang Jin; Ying Liao
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

10.  Comparison of IL-33 and IL-5 family mediated activation of human eosinophils.

Authors:  Evelyn L Angulo; Elizabeth M McKernan; Paul S Fichtinger; Sameer K Mathur
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.